The acute respiratory distress syndrome

Proceedings
Christopher WoodAriel M Modrykamien

Abstract

Acute respiratory distress syndrome (ARDS) is a prevalent cause of acute respiratory failure with high rates of mortality, as well as short- and long-term complications, such as physical and cognitive impairment. Therefore, early recognition of this syndrome and application of well-demonstrated therapeutic interventions are essential to change the natural course of this entity and bring about positive clinical outcomes. In this article, we review updated concepts in ARDS. Specifically, we discuss the current definition of ARDS, its risk factors, and the evidence supporting ventilation management, adjunctive therapies, and interventions required in refractory hypoxemia.

References

Dec 17, 1987·The New England Journal of Medicine·G R BernardC A Metz
May 1, 1985·Archives of Surgery·J A WeigeltW H Snyder
Aug 12, 1967·Lancet·D G AshbaughB E Levine
Feb 11, 1993·The New England Journal of Medicine·R RossaintW M Zapol
Feb 26, 1998·American Journal of Respiratory and Critical Care Medicine·P PelosiL Gattinoni
Jul 21, 1998·JAMA : the Journal of the American Medical Association·G U MeduriE A Tolley
Jul 29, 1999·Chest·A S Slutsky
May 4, 2000·The New England Journal of Medicine·UNKNOWN Acute Respiratory Distress Syndrome NetworkArthur Wheeler
Sep 1, 2001·The New England Journal of Medicine·L GattinoniUNKNOWN Prone-Supine Study Group
Nov 24, 2001·American Journal of Respiratory and Critical Care Medicine·L GattinoniL R Goodman
Jan 22, 2003·Intensive Care Medicine·Guillermo BugedoLuis Castillo
Apr 12, 2003·Critical Care Medicine·Carmen Sílvia Valente Barbas
Sep 24, 2004·Annals of Internal Medicine·Claude A Piantadosi, David A Schwartz
Nov 16, 2004·Critical Care Medicine·Jeffery S VenderMartin Nitsun
Nov 18, 2004·JAMA : the Journal of the American Medical Association·Claude GuerinMichel Kaidomar
Oct 21, 2005·The New England Journal of Medicine·Gordon D RubenfeldLeonard D Hudson
Dec 17, 2005·Critical Care : the Official Journal of the Critical Care Forum·Thomas Luecke, Paolo Pelosi
Mar 25, 2006·American Journal of Respiratory and Critical Care Medicine·Jordi ManceboRichard K Albert
Apr 21, 2006·The New England Journal of Medicine·Kenneth P SteinbergUNKNOWN National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network
May 23, 2006·The New England Journal of Medicine·UNKNOWN National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials NetworkAndrea L Harabin
Mar 27, 2007·BMJ : British Medical Journal·Neill K J AdhikariMaureen O Meade
Jul 28, 2007·American Journal of Respiratory and Critical Care Medicine·Salvatore GrassoTommaso Fiore
Aug 19, 2007·The Journal of Trauma·Soumitra R EachempatiPhilip S Barie
Feb 14, 2008·JAMA : the Journal of the American Medical Association·Alain MercatUNKNOWN Expiratory Pressure (Express) Study Group
Nov 12, 2009·JAMA : the Journal of the American Medical Association·Paolo TacconeUNKNOWN Prone-Supine II Study Group
Aug 31, 2010·American Journal of Respiratory and Critical Care Medicine·Ognjen GajicMichael Malinchoc
Sep 17, 2010·The New England Journal of Medicine·Laurent PapazianUNKNOWN ACURASYS Study Investigators
Apr 8, 2011·American Journal of Respiratory and Critical Care Medicine·Christian Brun-BuissonUNKNOWN REVA-SRLF A/H1N1v 2009 Registry Group
Apr 8, 2011·American Journal of Respiratory and Critical Care Medicine·Carolyn S CalfeeMitchell J Cohen
Jul 17, 2012·JAMA : the Journal of the American Medical Association·V Marco RanieriArthur S Slutsky
Jan 24, 2013·The New England Journal of Medicine·Duncan YoungUNKNOWN OSCAR Study Group
Jan 24, 2013·The New England Journal of Medicine·Niall D FergusonUNKNOWN Canadian Critical Care Trials Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings
Ariel M Modrykamien, Pooja Gupta
Nihon rinsho. Japanese journal of clinical medicine
Tatsuya Kubota
Polskie Archiwum Medycyny Wewnętrznej
E TulejaA Szczeklik
The Central African Journal of Medicine
L D Hudson
© 2021 Meta ULC. All rights reserved